ArticleTranslational cancer research2026
Optimization of temporal phase in multi-phase contrast-enhanced MRI for gross tumor volume determination in pancreatic cancer radiotherapy.
Article in Translational cancer research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Pancreatic cancer is characterized by an insidious onset and rapid progression, and the accurate determination of the gross tumor volume (GTV) constitutes a critical prerequisite for ensuring the efficacy of radiotherapy. Multiphase contrast-enhanced magnetic resonance imaging (CE-MRI) enables the dynamic visualization of tumor hemodynamic perfusion characteristics; however, the tissue discrimination capability varies substantially across different enhancement phases. To date, there is no universal consensus on the optimal imaging phase for GTV determination in pancreatic cancer. This study aimed to quantitatively analyze the differences in imaging and GTV determination of pancreatic cancer using multiphase CE-MRI, thereby providing a basis for selecting the optimal phase for GTV determination. Methods: Thirty patients with advanced pancreatic cancer [American Joint Committee on Cancer (AJCC) stage III-IV] who underwent magnetic resonance (MR) simulation were retrospectively enrolled in this study. MR T Results: The mean SI of the GTV was lower than that of the normal pancreatic tissue at each time phase (P<0.05), ranging from 9.93% to 45.01%. At CE-T Conclusions: The CE-T
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.